Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
Gratifii Director Bryan Zekulich Boosts Stake with 625,000 Shares in Shareholder-Approved Placement
Announcements

Gratifii Director Bryan Zekulich Boosts Stake with 625,000 Shares in Shareholder-Approved Placement

Gratifii Limited (GTI) has disclosed that director Bryan Zekulich acquired 625,000 fully paid ordinary shares and 312,500 unlisted options as part of a shareholder-approved placement on 21 July 2026. The acquisition, approved at an Extraordinary General Meeting held on 13 July 2026, represents an increase in Zekulich's direct and indirect shareholding in the digital engagement platform provider. The transaction highlights the company's capital raise activities and demonstrates director confidence in the company's direction.

NobleOak Enhances Board Governance with Alistair Muir as Independent Non-Executive Director
Announcements

NobleOak Enhances Board Governance with Alistair Muir as Independent Non-Executive Director

NobleOak (ASX: NOL), an independent Australian life insurance provider regulated by APRA, has confirmed the appointment of Alistair Muir as an independent Non-Executive Director, effective from 20 July 2026. The appointment follows the company's announcement on 22 June 2026 and represents a governance development for the ASX-listed insurer. Muir's formal director interest notice has been lodged with the exchange as required under listing rules.

Liberty Prime Series 2021-1 Redeems Three Floating Rate Note Classes, Marking Key Securitisation Milestone
Announcements

Liberty Prime Series 2021-1 Redeems Three Floating Rate Note Classes, Marking Key Securitisation Milestone

Liberty Prime Series 2021-1 (LP1) has announced the cessation of three classes of floating rate note securities following their redemption on 25 August 2025. The structured finance entity notified the ASX on 21 July 2026 of the completion of these debt security redemptions, which represent a maturity event for the 2021-1 securitisation program. The move reflects the scheduled repayment profile of the underlying mortgage-backed securities, a key milestone in the lifecycle of this debt structure.

CONNEQT Health Reports Record $1.3M Consumer Revenue and Advances FDA Review for SphygmoCloud Platform
Announcements

CONNEQT Health Reports Record $1.3M Consumer Revenue and Advances FDA Review for SphygmoCloud Platform

CONNEQT Health Limited (ASX: CQT), a digital health technology company, has reported record quarterly consumer revenue of $1.3 million for the June quarter 2026, representing 21% quarter-on-quarter growth. The company also achieved a significant strategic milestone by lodging an FDA Pre-Submission package for SphygmoCloud, its Software as a Medical Device platform, while successfully raising $5.5 million through a placement to fund continued expansion. The June quarter marks another period of commercial momentum across the company's diversified consumer, enterprise and research businesses.

MA Financial Group Lowers IPD Group Limited Stake to 7.68% Amid Strategic Shareholding Shift
Announcements

MA Financial Group Lowers IPD Group Limited Stake to 7.68% Amid Strategic Shareholding Shift

MA Financial Group Limited has reduced its voting interest in IPD Group Limited (ASX: IPG) from 8.89% to 7.68%, according to a substantial holder notice filed on 21 July 2026. The change, effective 17 July 2026, represents a decrease of 1.21 percentage points and involves 1.262 million ordinary shares. MA Financial Group manages the shareholding through its investment management and asset management subsidiaries operating from Sydney.

Tivan Limited Names Ellin Lede Director with Extensive Performance-Linked Equity Package
Announcements

Tivan Limited Names Ellin Lede Director with Extensive Performance-Linked Equity Package

Tivan Limited (ASX: TVN) has announced the appointment of Ellin Lede as a director, effective 21 July 2026. The company update reveals that the new director holds a material equity stake comprising ordinary shares, multiple classes of performance rights, and options, alongside an executive services contract that includes performance-based incentives tied to key project milestones at the company's fluorite, tungsten, and mineral exploration assets.

Xero (ASX:XRO): Why Is Software Quality Facing a Bigger Test?
Technology Stocks

Xero (ASX:XRO): Why Is Software Quality Facing a Bigger Test?

Xero remains in focus as software quality, subscriber resilience, recurring revenue and disciplined execution shape discussion across Australia's technology sector during a more selective market environment.

  • July 21, 2026 04:14 PM AEST
  • Sam
WiseTech (ASX:WTC): Why Is the Tech Reset Worth Watching?
Technology Stocks

WiseTech (ASX:WTC): Why Is the Tech Reset Worth Watching?

WiseTech remains in focus as workflow depth, customer expansion and disciplined software execution reinforce its position within Australia's evolving technology sector amid a more selective market environment.

  • July 21, 2026 04:14 PM AEST
  • Sam
Is CSL (ASX:CSL) Turning the Corner as Healthcare Heals?
Healthcare Stocks

Is CSL (ASX:CSL) Turning the Corner as Healthcare Heals?

The blood-products heavyweight steadied and pushed higher as the Australian healthcare sector rebounded sharply from a multi-year low. After a punishing year that left the name deeply out of favour, the bounce hinted that the worst of the sector's gloom may be easing. Tickers used:ASX:CSL, ASX:TLX Alternate headline 1:Can CSL's rebound outlast the ASX healthcare bounce? Alternate headline 2:ASX healthcare snaps back and CSL leads the turn

  • July 21, 2026 04:11 PM AEST
  • Sam
Toubani Resources Grants 36.4 Million Options at $0.60 Exercise Price in Avanti Gold Acquisition Deal
Announcements

Toubani Resources Grants 36.4 Million Options at $0.60 Exercise Price in Avanti Gold Acquisition Deal

Toubani Resources Limited (TRE) has issued 36.4 million unquoted options as part consideration for Avanti Gold Corporation shares, marking a significant step in the company's acquisition strategy. The options are exercisable at $0.60 per share and expire on 21 July 2029. The issuance, completed on 21 July 2026, follows a placement announcement made on 29 June 2026 and represents a material expansion of the company's option holder base.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.